Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity

References

• Robertson MS, Hayashi SS, Camet ML, Trinkaus K, Henry J, Hayashi RJ. Asymmetric sensorineural hearing loss is a risk factor for late-onset hearing loss in pediatric cancer survivors following cisplatin treatment. Pediatr Blood Cancer. 2018;18:e27494. doi:10.1002/pbc.2749.
   Google Scholar
• Kalyanam B, Sarala N, Azeem Mohiyuddin SM, Diwakar R. Auditory function and quality of life in patients receiving cisplatin chemotherapy in head and neck cancer: a case series follow-up study. J Cancer Res Ther. 2018;14(5):1099–1104. doi:10.4103/0973-1482.18842630197356
   PubMed Web of Science ®Google Scholar
• Biswas B, Ganguly S, Ghosh J, Batra A. Cisplatin-induced hearing loss in children with cancer. Natl Med J India. 2017;30(6):327–328. doi:10.4103/0970-258X.23907330117444
   PubMedGoogle Scholar
• Waissbluth S, Del Valle Á, Chuang A, Becker A. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients. Int J Pediatr Otorhinolaryngol. 2018;111:174–179. doi:10.1016/j.ijporl.2018.06.02129958605
   PubMedGoogle Scholar
• Brock PR, Maibach R, Childs M, et al. Sodium thiosulfate for protection from cisplatin-induced hearing loss. N Engl J Med. 2018;378(25):2376–2385. doi:10.1056/NEJMoa180110929924955
   PubMed Web of Science ®Google Scholar
• Hazlitt RA, Min J, Zuo J. Progress in the development of preventative drugs for cisplatin-induced hearing loss. J Med Chem. 2018;61(13):5512–5524. doi:10.1021/acs.jmedchem.7b0165329361217
   PubMedGoogle Scholar
• Marshak T, Steiner M, Kaminer M, Levy L, Shupak A. Prevention of cisplatin-induced hearing loss by intratympanic dexamethasone: a randomized controlled study. Otolaryngol Head Neck Surg. 2014;150(6):983–990. doi:10.1177/019459981452489424618499
   PubMed Web of Science ®Google Scholar
• Waissbluth S, Salehi P, He X, Daniel SJ. Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity. Eur Arch Otorhinolaryngol. 2013;270(5):1597–1605. doi:10.1007/s00405-012-2150-022907029
   PubMed Web of Science ®Google Scholar
• Murphy D, Daniel SJ. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model. Otolaryngol Head Neck Surg. 2011;145(3):452–457. doi:10.1177/019459981140667321521888
   PubMed Web of Science ®Google Scholar
• Lyu A-R, Kim DH, Lee SH, Shin D-S, Shin S-A, Park Y-H. Effects of dexamethasone on intracochlear inflammation and residual hearing after cochleostomy: a comparison of administration routes. PLoS One. 2018;13(3):e0195230. doi:10.1371/journal.pone.019523029601595
   PubMed Web of Science ®Google Scholar
• Özel HE, Özdoğan F, Gürgen SG, Esen E, Genç S, Selçuk A. Comparison of the protective effects of intratympanic dexamethasone and methylprednisolone against cisplatin-induced ototoxicity. J Laryngol Otol. 2016;130(3):225–234. doi:10.1017/S002221511500347326830667
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Minamiyama S, Ohya T, et al. Daily cisplatin and weekly docetaxel versus weekly cisplatin intra-arterial chemoradiotherapy for late T2-3 tongue cancer: a pilot and feasibility trial. Medicina (Kaunas). 2018;54(4):52.
   PubMed Web of Science ®Google Scholar
• Yu DH, Sun CL, Zheng ZZ, et al. Inner ear delivery of dexamethasone using injectable silk-polyethylene glycol (PEG) hydrogel. Int J Pharm. 2016;503(1–2):229–237. doi:10.1016/j.ijpharm.2016.02.04826972377
   PubMedGoogle Scholar
• Kim Do K, Sim BR, Khang G. Nature-derived aloe vera gel blended silk fibroin film scaffolds for cornea endothelial cell regeneration and transplantation. ACS Appl Mater Interfaces. 2016;8(24):15160–15168. doi:10.1021/acsami.6b0490127243449
   PubMedGoogle Scholar
• Fernández-García L, Marí-Buyé N, Barios JA, et al. Safety and tolerability of silk fibroin hydrogels implanted into the mouse brain. Acta Biomater. 2016;45:262–275. doi:10.1016/j.actbio.2016.09.00327592819
   PubMedGoogle Scholar
• Kalinec G, Thein P, Park C, Kalinec F. HEI-OC1 cells as a model for investigating drug cytotoxicity. Hear Res. 2016;335:105–117. doi:10.1016/j.heares.2016.02.01926930622
   PubMed Web of Science ®Google Scholar
• Wang XQ, Partlow B, Liu J, et al. Injectable silk-polyethylene glycol hydrogels. Acta Biomater. 2015;12:51–61. doi:10.1016/j.actbio.2014.10.02725449912
   PubMed Web of Science ®Google Scholar
• Sheth S, Mukherjea D, Rybak LP, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and otoprotection. Front Cell Neurosci. 2017;11:338. doi:10.3389/fncel.2017.0033829163050
   PubMed Web of Science ®Google Scholar
• Yang KJ, Son J, Jung SY, et al. Optimized phospholipid-based nanoparticles for inner ear drug delivery and therapy. Biomaterials. 2018;171:133–143. doi:10.1016/j.biomaterials.2018.04.03829689410
   PubMed Web of Science ®Google Scholar
• Mäder K, Lehner E, Liebau A, Plontke SK. Controlled drug release to the inner ear: concepts, materials, mechanisms, and performance. Hear Res. 2018;368:49–66. doi:10.1016/j.heares.2018.03.00629576310
   PubMed Web of Science ®Google Scholar
• Kuang X, Zhou S, Guo W, Wang Z, Sun Y, Liu H. SS-31 peptide enables mitochondrial targeting drug delivery: a promising therapeutic alteration to prevent hair cell damage from aminoglycosides. Drug Deliv. 2017;24(1):1750–1761. doi:10.1080/10717544.2017.140222029214897
   PubMed Web of Science ®Google Scholar
• Fernandez R, Harrop-Jones A, Wang X, Dellamary L, LeBel C, Piu F. The sustained-exposure dexamethasone formulation OTO-104 offers effective protection against cisplatin-induced hearing loss. Audiol Neurootol. 2016;21(1):22–29. doi:10.1159/00044183326789647
   PubMed Web of Science ®Google Scholar
• Honeder C, Landegger LD, Engleder E, et al. Effects of intraoperatively applied glucocorticoid hydrogels on residual hearing and foreign body reaction in a guinea pig model of cochlear implantation. Acta Otolaryngol. 2015;135(4):313–319. doi:10.3109/00016489.2014.98675825720453
   PubMed Web of Science ®Google Scholar
• Wu J, Xie X, Zheng Z, Li G, Wang X, Wang Y. Effect of pH on polyethylene glycol (PEG)-induced silk microsphere formation for drug delivery. Mater Sci Eng C Mater Biol Appl. 2017;80:549–557. doi:10.1016/j.msec.2017.05.07228866200
   PubMedGoogle Scholar
• Bing G, Sun X, Papadimitrakopoulos F, Diane JB. Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere/PVA hydrogel composites. J Control Release. 2016;228:170–178. doi:10.1016/j.jconrel.2016.03.01126965956
   PubMedGoogle Scholar
• Sarafraz Z, Ahmadi A, Daneshi A. Transtympanic injections of N-acetylcysteine and dexamethasone for prevention of cisplatin-induced ototoxicity: double blind randomized clinical trial. Int Tinnitus J. 2018;22(1):40–45. doi:10.5935/0946-5448.2018000729993216
   PubMedGoogle Scholar
• Martín-Saldaña S, Palao-Suay R, Aguilar MR, et al. pH-sensitive polymeric nanoparticles with antioxidant and anti-inflammatory properties against cisplatin-induced hearing loss. J Control Release. 2018;270:53–64. doi:10.1016/j.jconrel.2017.11.03229197586
   PubMed Web of Science ®Google Scholar
• Capelo IOJ, Batista AMA, Brito YNF, Diniz KB, Brito GAC, Freitas MR. Study of the protective effect of dexamethasone on cisplatin-induced ototoxicity in rats. Acta Cir Bras. 2017;32(10):873–880. doi:10.1590/s0102-86502017010000000929160374
   PubMedGoogle Scholar
• Honeder C, Engleder E, Schöpper H, et al. Sustained release of triamcinolone acetonide from an intratympanically applied hydrogel designed for the delivery of high glucocorticoid doses. Audiol Neurootol. 2014;19(3):193–202. doi:10.1159/00035816524714604
   PubMedGoogle Scholar
• El Kechai N, Bochot A, Huang N, Nguyen Y, Ferrary E, Agnely F. Effect of liposomes on rheological and syringeability properties of hyaluronic acid hydrogels intended for local injection of drugs. Int J Pharm. 2015;487(1–2):187–196. doi:10.1016/j.ijpharm.2015.04.01925882015
   PubMedGoogle Scholar
• Zhong T, Jiang Z, Wang P, Bie S, Zhang F, Zuo B. Silk fibroin/copolymer composite hydrogels for the controlled and sustained release of hydrophobic/hydrophilic drugs. Int J Pharm. 2015;494(1):264–270. doi:10.1016/j.ijpharm.2015.08.03526283278
   PubMedGoogle Scholar
• Wang XL, Chen YM, Tao Y, Gao YG, Yu DH, Wu H. A666-conjugated nanoparticles target prestin of outer hair cells preventing cisplatin-induced hearing loss. Int J of Nanomed. 2018;13:7517–7531. doi:10.2147/IJN.S170130
   PubMed Web of Science ®Google Scholar
• Sockalingam R, Freeman S, Cherny TL, Sohmer H. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals. Am J Otol. 2000;21(4):521–527.10912698
   PubMedGoogle Scholar
• Hughes AL, Hussain N, Pafford R, Parham K. Dexamethasone otoprotection in a multidose cisplatin ototoxicity mouse model. Otolaryngol Head Neck Surg. 2014;150(1):115–120. doi:10.1177/019459981351194824233060
   PubMedGoogle Scholar